The importance of comprehensive transition of care in women with Turner's syndrome;Het belang van zorgvuldige transitie van zorg voor patiënten met het syndroom van Turner

Nederlands Tijdschrift voor Geneeskunde

Volumn 151, Issue 29, 2007, Pages 1612-1615

  De Muinck Keizer Schrama, S M P F ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL FEATURE; COMORBIDITY; EARLY DIAGNOSIS; FEMALE; HUMAN; OVARY INSUFFICIENCY; PATIENT CARE; REVIEW; SECONDARY AMENORRHEA; TURNER SYNDROME; X CHROMOSOME;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CHROMOSOMES, HUMAN, X; CONTINUITY OF PATIENT CARE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INFERTILITY, FEMALE; QUALITY OF HEALTH CARE; TURNER SYNDROME; WOMEN'S HEALTH; WOMEN'S HEALTH SERVICES;

EID: 34547143634     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Stratakis CA, Rennert OM. Turner syndrome: molecular and cytogenetics, dysmorphology, endocrine, and other clinical manifestations and their management. Endocrinologist. 1994;4:442-53.
2. Elsheikh M, Dunger DB, Conway GS, Wass JAH. Turner's syndrome in adulthood. Endocr Rev. 2002;23:120-40.
3. Naeraa RW, Gravholt CH, Hansen J, Nielsen J, Juul S. Mortality in Turner syndrome. In: Albertsson-Wikland K, Ranke MB, editors. Turner syndrome in a lifespan prospective: research and clinical aspects. Amsterdam: Elsevier; 1995. p. 323.
4. Swerdlow AJ, Hermon C, Jacobs PA, Alberman E, Beral V, Daker M, et al. Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann Hum Genet. 2001;65(Pt 2):177-88.
5. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab. 2006;91:3897-902.
6. Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol. 1998;51:147-58.
7. Canto P, Kofman-Alfaro S, Jimenez AL, Soderlund D, Barron C, Reyes E, et al. Gonadoblastoma in Turner syndrome patients with non-mosaic 45,X karyotype and Y chromosome sequences. Cancer Genet Cytogenet. 2004;150:70-2.
8. Conway GS. Considerations for transition from paediatric to adult endocrinology: women with Turner's syndrome. Growth Horm IGF Res. 2004;14(Suppl A):S77-84.
9. Massa G, Verlinde F, Schepper J de, Thomas M, Bourguignon JP, Craen M, et al. Trends in age at diagnosis of Turner syndrome. Belgian Study Group for Paediatric Endocrinology. Arch Dis Child. 2005;90:267-8.
10. Pareren YK van, Muinck Keizer-Schrama SMPF de, Stijnen T, Sas TC, Jansen M, Otten BJ, et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab. 2003;88:1119-25.
11. Rubin K. Transitioning the patient with Turner's syndrome from paediatric to adult care. J Pediatr Endocrinol Metab. 2003;16(Suppl 3):651-9.
12. Broekhuijsen-van Henten DM, Vroede M de. Follow-up van volwassen vrouwen met het syndroom van Turner bij een Utrechts cohort. Ned Tijdschr Geneeskd. 2007;151:1630-4.
13. Kirk J, Clayton P. Specialist services and transitional care in paediatric endocrinology in the UK and Ireland. Clin Endocrinol (Oxf). 2006;65:59-63.
14. Freriks K, Beerendonk CCM, Timmermans J, Braat DDM, Hermus ARMM, Timmers HJLM. Het syndroom van Turner op volwassen leeftijd: het belang van multidisciplinaire zorg. Ned Tijdschr Geneeskd. 2007;151:1616-22.